tradingkey.logo
tradingkey.logo
Search

ATAI Life Sciences NV

ATAI
Add to Watchlist
7.180USD
0.0000.00%
Close 07-31 16:00ETQuotes delayed by 15 min
2.66BMarket Cap
LossP/E TTM

ATAI Financials

See ATAI Life Sciences NV's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

ATAI Life Sciences NV Earnings Date

Latest Release
May 12, 2026
EPS / Forecast
-0.08/-0.10
Revenue / Forecast
954.00K/11.11K
Period
FY2025 Earnings
Revenue(YoY)
4.09M
1227.60%
EPS(YoY)
-2.91
-212.63%
Analyst Rating
HOLD
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2020Q4
Financial Indicators
EPS
44.43%-0.08
-614.36%-1.73
-71.51%-0.28
60.52%-0.14
10.81%-0.15
-122.14%-0.24
-157.63%-0.16
-68.48%-0.36
20.96%-0.17
61.59%-0.11
--0.28
---0.21
---0.21
---0.28
---0.69
----
----
----
----
----
----
Revenue
-38.65%954.00K
--1.07M
1772.50%749.00K
163.37%719.00K
--1.56M
----
-54.02%40.00K
58.72%273.00K
-100.00%0.00
-52.63%18.00K
262.50%87.00K
1.18%172.00K
--37.00K
-83.48%38.00K
-90.98%24.00K
--170.00K
-100.00%0.00
--230.00K
--266.00K
--0.00
----
Net Profit
-12.68%-29.78M
-1298.46%-544.81M
-132.34%-61.07M
51.62%-27.73M
1.06%-26.43M
-112.98%-38.96M
-159.41%-26.29M
-73.45%-57.31M
19.38%-26.71M
59.36%-18.29M
230.56%44.24M
9.77%-33.04M
10.13%-33.13M
49.36%-45.01M
-8.76%-33.89M
24.44%-36.62M
-5458.87%-36.87M
-2.64%-88.88M
62.55%-31.16M
-196.27%-48.46M
----
Net Margin
-83.55%-3123.90%
---51110.51%
87.60%-8157.28%
81.64%-3858.97%
---1701.93%
----
-231.95%-65777.50%
-7.03%-21014.29%
----
13.37%-106344.44%
--49851.72%
---19634.30%
---92848.65%
---122760.53%
---56804.10%
----
----
----
----
----
----
Gross Margin
0.00%100.00%
--100.00%
0.00%100.00%
0.00%100.00%
--100.00%
----
0.00%100.00%
0.00%100.00%
----
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
Debt to assets ratio
----
-100.00%0.00%
-100.00%0.00%
-62.14%3.26%
66.40%12.15%
142.01%14.74%
130.95%11.51%
42.64%8.60%
34.84%7.30%
23.08%6.09%
--4.99%
--6.03%
--5.42%
--4.95%
--4.38%
----
----
----
----
----
----
Revenue
-38.65%954.00K
--1.07M
1772.50%749.00K
163.37%719.00K
--1.56M
----
-54.02%40.00K
58.72%273.00K
-100.00%0.00
-52.63%18.00K
262.50%87.00K
1.18%172.00K
--37.00K
-83.48%38.00K
-90.98%24.00K
--170.00K
-100.00%0.00
--230.00K
--266.00K
--0.00
----
Operating profit
-60.36%-30.90M
-27.60%-38.62M
-25.81%-28.44M
1.39%-25.27M
13.14%-19.27M
9.82%-30.27M
15.77%-22.60M
19.56%-25.63M
26.08%-22.18M
10.66%-33.56M
30.16%-26.83M
8.97%-31.86M
10.25%-30.01M
2.75%-37.56M
-15.17%-38.42M
34.40%-35.00M
-765.91%-33.44M
48.73%-38.63M
-351.68%-33.36M
-835.27%-53.36M
----
Net Profit
-12.68%-29.78M
-1298.46%-544.81M
-132.34%-61.07M
51.62%-27.73M
1.06%-26.43M
-112.98%-38.96M
-159.41%-26.29M
-73.45%-57.31M
19.38%-26.71M
59.36%-18.29M
230.56%44.24M
9.77%-33.04M
10.13%-33.13M
49.36%-45.01M
-8.76%-33.89M
24.44%-36.62M
-5458.87%-36.87M
-2.64%-88.88M
62.55%-31.16M
-196.27%-48.46M
----
Current assets
115.62%250.07M
244.07%275.68M
14.54%130.67M
-12.91%102.68M
-1.30%115.98M
-56.83%80.13M
-47.15%114.07M
-51.43%117.91M
-56.15%117.50M
-35.37%185.59M
-32.02%215.82M
-24.98%242.77M
-23.18%267.93M
-23.44%287.14M
-28.15%317.48M
-29.28%323.61M
--348.79M
--375.08M
--441.86M
--457.59M
----
Total current liabilities
-12.41%24.96M
-5.90%23.48M
-15.78%16.54M
44.79%25.55M
89.84%28.50M
24.01%24.95M
-0.26%19.64M
-1.57%17.64M
-24.76%15.01M
1.12%20.12M
-24.00%19.70M
-18.36%17.93M
-9.68%19.95M
-4.96%19.90M
69.18%25.91M
54.79%21.96M
--22.09M
--20.93M
--15.32M
--14.19M
----
Total assets
35.29%264.88M
83.66%292.72M
21.42%239.82M
-12.32%189.20M
-27.25%195.78M
-45.69%159.39M
-35.92%197.52M
-14.91%215.78M
-4.13%269.12M
-3.92%293.48M
-10.03%308.22M
-27.32%253.59M
-26.85%280.72M
-26.25%305.44M
-29.23%342.60M
-31.04%348.94M
--383.73M
--414.17M
--484.11M
--505.96M
----
Total liabilities
51.92%66.10M
65.11%70.72M
56.07%79.91M
-4.16%45.28M
-5.13%43.51M
-12.87%42.83M
28.95%51.20M
24.47%47.24M
14.44%45.86M
23.91%49.16M
-14.64%39.71M
31.73%37.96M
36.43%40.08M
40.66%39.67M
117.89%46.52M
36.78%28.81M
--29.38M
--28.21M
--21.35M
--21.07M
----
Total equity
30.54%198.78M
90.47%222.00M
9.29%159.91M
-14.60%143.93M
-31.79%152.27M
-52.29%116.55M
-45.51%146.32M
-21.84%168.53M
-7.22%223.26M
-8.07%244.32M
-9.31%268.51M
-32.64%215.64M
-32.09%240.64M
-31.14%265.77M
-36.02%296.08M
-33.98%320.12M
--354.36M
--385.96M
--462.76M
--484.89M
----
Net operating income
-18.21%-21.09M
-95.43%-47.48M
-20.27%-23.26M
13.15%-14.09M
20.96%-17.84M
-10.63%-24.30M
-4.94%-19.34M
28.24%-16.23M
-6.93%-22.57M
28.01%-21.96M
34.28%-18.43M
-3.11%-22.61M
11.99%-21.11M
-48.74%-30.50M
0.23%-28.05M
---21.93M
---23.99M
-230.05%-20.51M
-416.25%-28.11M
----
---6.21M
Net investment
-96.60%-21.65M
-715.00%-40.34M
-371.95%-67.55M
-39.98%9.78M
-196.02%-11.01M
897.08%6.56M
153.44%24.84M
174.08%16.30M
-28.39%11.47M
-101.03%-823.00K
-170.38%-46.48M
-20.81%-22.00M
107.46%16.02M
264.60%80.05M
10857.33%66.05M
---18.21M
---214.74M
-1157.97%-48.63M
88.58%-614.00K
----
---3.87M
Net financing
-98.62%821.00K
92351.30%142.38M
1120.76%59.74M
2279.45%7.76M
--59.60M
101.82%154.00K
--4.89M
426.00%326.00K
-100.00%0.00
-817.68%-8.46M
-100.00%0.00
-105.57%-100.00K
56.06%206.00K
-153.51%-922.00K
410.21%19.78M
--1.79M
--132.00K
-97.90%1.72M
-78.53%3.88M
----
--81.98M

FAQs

What is the total revenue of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its total revenue reached 4.09M, with a year-on-year change of 308.00K.

What are the current assets of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its current assets were 275.68M, with a year-on-year change of 244.07.

What are the total assets of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its total assets of ATAI Life Sciences NV were 292.72M, with a year-on-year change of 83.66.

What are the total liabilities of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its total liabilities of ATAI Life Sciences NV were 70.72M, with a year-on-year change of 65.11.

What is the total equity of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its total equity of ATAI Life Sciences NV was 222.00M, with a year-on-year change of 90.47.

What is the net operating income of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its net operating income of ATAI Life Sciences NV was -111.26M, with a year-on-year change of -11.49.

What is the net investment of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its net investment of ATAI Life Sciences NV was -109.13M, with a year-on-year change of -284.42.

What is the net financing of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its net financing of ATAI Life Sciences NV was 269.48M, with a year-on-year change of 4914.53.

What is the Earnings Per Share (EPS) of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its Earnings Per Share (EPS) was -2.91, with a year-on-year change of -212.63.

What is the net income of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its net income was -660.05M, with a year-on-year change of -342.19.

What is the net margin of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its net profit margin was -16144.46, with a year-on-year change of 66.86.

What is the Return on Equity (ROE) of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its Return on Equity (ROE) was -390.36, with a year-on-year change of -369.76.

What is the Return on Assets (ROA) of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its Return on Assets (ROA) was -292.03, with a year-on-year change of -340.69.

What is the operating profit of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its operating profit was -111.26M, with a year-on-year change of -11.49.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.